Dunhill Financial’s Avidity Biosciences RNAM Stock Holding History

Dunhill Financial’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$129	–	2049
2025 Q4	$129	Buy	+2	New	+$129	﹤0.01%	1277

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Dunhill Financial's RNAM Position: Q1 2026 in Review

Dunhill Financial sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 2 shares — an estimated $129 sold.

Dunhill Financial first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $129 in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Dunhill Financial reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Dunhill Financial sold 2 Avidity Biosciences shares in Q1 2026, an estimated $129.
Dunhill Financial first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Dunhill Financial's Avidity Biosciences position peaked at $129 in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.